These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 19072462

  • 21. Human papillomavirus vaccine trials and tribulations: Vaccine efficacy.
    Handler NS, Handler MZ, Majewski S, Schwartz RA.
    J Am Acad Dermatol; 2015 Nov; 73(5):759-67; quiz 767-8. PubMed ID: 26475535
    [Abstract] [Full Text] [Related]

  • 22. [HPV vaccination with quadrivalent or nonavalent vaccine: an opportunity to eliminate genital warts as well].
    van Bergen JEAM.
    Ned Tijdschr Geneeskd; 2020 Jan 09; 164():. PubMed ID: 32073799
    [Abstract] [Full Text] [Related]

  • 23. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V, Murtagh J.
    Issues Emerg Health Technol; 2007 Dec 09; (109):1-8. PubMed ID: 18062141
    [Abstract] [Full Text] [Related]

  • 24. Reducing the health burden of HPV infection through vaccination.
    Soper D.
    Infect Dis Obstet Gynecol; 2006 Dec 09; 2006 Suppl():83084. PubMed ID: 16967913
    [Abstract] [Full Text] [Related]

  • 25. Preventing cervical cancer and genital warts - How much protection is enough for HPV vaccines?
    Stanley M.
    J Infect; 2016 Jul 05; 72 Suppl():S23-8. PubMed ID: 27211079
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Human papillomavirus vaccines: current issues & future.
    Kawana K, Yasugi T, Taketani Y.
    Indian J Med Res; 2009 Sep 05; 130(3):341-7. PubMed ID: 19901444
    [Abstract] [Full Text] [Related]

  • 28. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Navarro-Illana E, López-Lacort M, Navarro-Illana P, Vilata JJ, Diez-Domingo J.
    Vaccine; 2017 Jun 05; 35(25):3342-3346. PubMed ID: 28499554
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Human papillomavirus vaccine trials and tribulations: Clinical perspectives.
    Handler MZ, Handler NS, Majewski S, Schwartz RA.
    J Am Acad Dermatol; 2015 Nov 05; 73(5):743-56; quiz 757-8. PubMed ID: 26475534
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Vaccines against human papillomavirus infections: protection against cancer, genital warts or both?
    Joura EA, Pils S.
    Clin Microbiol Infect; 2016 Dec 01; 22 Suppl 5():S125-S127. PubMed ID: 28034371
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA.
    Pharmacotherapy; 2011 Mar 01; 31(3):280-97. PubMed ID: 21361739
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Developing an HPV vaccine to prevent cervical cancer and genital warts.
    Bryan JT.
    Vaccine; 2007 Apr 20; 25(16):3001-6. PubMed ID: 17289220
    [Abstract] [Full Text] [Related]

  • 38. Human papillomavirus quadrivalent vaccine: a look behind the numbers.
    Flaherty DK, Alkhateeb FM.
    Ann Pharmacother; 2009 Apr 20; 43(4):740-4. PubMed ID: 19276314
    [Abstract] [Full Text] [Related]

  • 39. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
    Chelimo C, Wouldes TA, Cameron LD, Elwood JM.
    J Infect; 2013 Mar 20; 66(3):207-17. PubMed ID: 23103285
    [Abstract] [Full Text] [Related]

  • 40. Quadrivalent human vaccine - a call to action and for additional research.
    Krogstad P, Cherry JD.
    Pediatr Res; 2007 Nov 20; 62(5):527. PubMed ID: 18049369
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.